ranitidine has been researched along with Hyperparathyroidism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunningham, J; Segre, G; Slatopolsky, E | 1 |
| De Jong, MJ; Juttmann, JR; Lockefeer, JH; Pols, HA | 1 |
| Bonfils, S; Bonnefond, A; Labeille, D; Lehy, T; Mignon, M; Ruszniewski, P | 1 |
3 other study(ies) available for ranitidine and Hyperparathyroidism
| Article | Year |
|---|---|
Histamine H2 receptor blockade in patients with hyperparathyroidism.
Topics: Cimetidine; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Parathyroid Hormone; Ranitidine; Uremia | 1984 |
Failure of H2-receptor antagonists to affect serum calcium and immunoreactive parathyroid hormone levels in normal subjects and patients with primary hyperparathyroidism.
Topics: Adult; Aged; Animals; Calcium; Cimetidine; Dogs; Drug Evaluation; Female; Furans; Guanidines; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Ranitidine | 1983 |
Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment.
Topics: Carcinoid Tumor; Cell Division; Cimetidine; Female; Gastrectomy; Humans; Hyperparathyroidism; Middle Aged; Multiple Endocrine Neoplasia; Ranitidine; Staining and Labeling; Stomach Neoplasms; Zollinger-Ellison Syndrome | 1987 |